Research Paper Volume 15, Issue 24 pp 14996—15024
ATRX is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network
Figure 1. Eliminating batch effect between different sequencing platforms. (A) Workflow of this study. (B) Eliminating the batch effect of GSE24460, GSE862 and GSE22513, and combing the three datasets into a singular dataset, named GSE1. (C) Volcano plots of DEGs in GSE1. (D) TOP10 BP enrichment analysis of DEGs in GSE1. (E) KEGG enrichment of the TOP10 terms in GSE1.